(NASDAQ: NXGL) Nexgel's forecast annual revenue growth rate of 41.41% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Nexgel's revenue in 2026 is $11,665,000.On average, 3 Wall Street analysts forecast NXGL's revenue for 2026 to be $140,216,607, with the lowest NXGL revenue forecast at $134,711,849, and the highest NXGL revenue forecast at $144,337,032. On average, 3 Wall Street analysts forecast NXGL's revenue for 2027 to be $204,921,942, with the lowest NXGL revenue forecast at $196,892,813, and the highest NXGL revenue forecast at $210,956,003.
In 2028, NXGL is forecast to generate $268,593,099 in revenue, with the lowest revenue forecast at $258,055,885 and the highest revenue forecast at $276,491,938.